Sat, Apr 19, 2014, 9:31 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Dendreon Corp. Message Board

  • jozej jozej Jul 17, 2013 10:39 AM Flag

    Comparing Provenge with to therapies is like comparing apples to oranges

    I really can't believe how naive we can be...Bashers compare Provenge to Zytinga and other prostate cancer treatments and talk us about costs...It is like comparing costs for the journey from Madrid (Spain) to St. Petersburg (Russia). You can get (or try to get) from one point to another with the best new Mercedes S or BMW 7 series or with Fiat chinquechento.
    Costs, time, comfort...will be different and your spine, head, neck... will behave differently after you finish the journey, of course if you finish it. The same is with Provenge and other treatments...Only patients will know the real advantages and they will tell others...on the long way quality and especially quality of life will prevail. Don't forget only Provenge is immunoterapy and helps your body to build it's own immunosystem that it can fight back! Which terapy is more natural, please explain me? Don't underestimate the mother nature, it always win at the end and so does everything what supports natural behaviour. When we are in area of prostate cancer medical treatments, Provenge immunoterapy is the Nature!

    GLTA!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
DNDN
2.65-0.04(-1.49%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST